AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Sitasafe-M Tablet

Prescription Icon
Prescription Required

Marketer

Dr. Ethix's Product & Services Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitasafe-M Tablet

Diabexe Duo tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps prevent severe diabetic complications like renal impairment and vision loss, and may lessen the risk of cardiovascular events. Diabexe Duo may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, blood glucose readings, and concurrent medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes efficacy; discontinuation should only occur under medical supervision. Adherence to your prescribed diet and exercise regimen is crucial for effective diabetes management, as lifestyle significantly impacts blood sugar control. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, and pharyngitis. Hypoglycemia is a potential side effect, particularly when combined with insulin or sulfonylureas; understanding its recognition and treatment is essential. This medication isn't suitable for all patients. Inform your physician of any history of kidney, liver, or heart disease, pancreatic issues, or significant alcohol consumption before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Potential drug interactions exist; therefore, disclose all medications to your doctor to ensure safety. Alcohol consumption should be minimized due to its hypoglycemic effect. Your doctor will monitor your renal function and blood glucose levels throughout treatment.

Uses of Sitasafe-M Tablet

Managing type 2 diabetes

Major Benefits of Sitasafe-M Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not chew, crush, or divide it. Administer Sitasafe-M Tablet with a meal.

Common Side effects of Sitasafe-M Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitasafe-M Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Sitasafe-M Tablet with a meal.

How Sitasafe-M Tablet works:

Sitagliptin and metformin, the components of Sitasafe-M tablets, work synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces glucose production in the liver, slows intestinal glucose absorption, and boosts insulin sensitivity. This combined action leads to improved glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Sitasafe-M Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitasafe-M Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitasafe-M Tablet while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Sitasafe-M Tablets, potentially requiring a modified dosage. Consult a physician for guidance. Sitasafe-M Tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

The use of Sitasafe-M Tablets is likely inadvisable for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Sitasafe-M Tablet :

Should you forget a dose of Sitasafe-M Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitasafe-M Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Sitasafe-M Tablet

Sitasafe-M Tablet combines sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged Sitasafe-M Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, supplemental vitamin B12 is recommended at least annually by some researchers.
Sitasafe-M Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitasafe-M Tablets are contraindicated in patients with hypersensitivity to any ingredient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitasafe-M tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin + Metformin (Sitasafe-M Tablet) can, rarely, cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This risk is higher in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, stop taking Sitasafe-M and seek immediate medical attention.
Sitasafe-M Tablets combine sitagliptin and metformin to treat type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18 years old.
Sitasafe-M Tablet may cause common side effects including low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Sitasafe-M Tablets are contraindicated in patients with known hypersensitivity to any ingredient. This medication should also be avoided in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitasafe-M tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin + Metformin (Sitasafe-M Tablet) can, rarely, cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency involving high blood lactic acid levels. This risk is increased in patients with kidney disease, the elderly, and heavy alcohol users. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If these occur, stop taking Sitasafe-M and seek immediate medical attention.
Prolonged Sitasafe-M Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia and neurological issues, including numbness and tingling in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitasafe-M Tablet combines sitagliptin and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Sitasafe-M Tablet may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitasafe-M Tablets are contraindicated in patients with allergies to any ingredient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitasafe-M Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin + Metformin (Sitasafe-M Tablet) can cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those consuming large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitasafe-M and seek immediate medical attention.
Prolonged Sitasafe-M Tablet use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness, tingling in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitasafe-M Tablet
211
MRP 245
13% off